🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 10 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/02/2011 11,10 11,28 11,10 11,16 -0,53% 1,62% 34.917
04/02/2011 11,34 11,52 11,16 11,22 -1,58% 3,17% 43.617
03/02/2011 11,40 11,46 11,28 11,40 -0,52% 1,58% 16.500
02/02/2011 11,40 11,58 11,40 11,46 +0,00% 1,58% 30.950
01/02/2011 11,46 11,64 11,34 11,46 +0,53% 2,62% 38.667
31/01/2011 11,52 11,76 11,40 11,40 +0,00% 3,13% 37.083
28/01/2011 11,46 11,58 11,16 11,40 -0,52% 3,66% 60.617
27/01/2011 11,46 11,70 11,34 11,46 -0,52% 3,14% 185.167
26/01/2011 11,34 11,52 11,22 11,52 +2,13% 2,65% 26.017
25/01/2011 11,46 11,46 11,22 11,28 -2,08% 2,09% 64.967
24/01/2011 11,28 11,52 11,22 11,52 +2,67% 2,66% 33.450
21/01/2011 11,82 11,94 11,22 11,22 -4,59% 6,09% 236.783
20/01/2011 12,12 12,30 10,86 11,76 -4,39% 11,88% 356.717
19/01/2011 12,54 12,60 12,24 12,30 -1,91% 2,87% 95.367
18/01/2011 12,60 12,60 12,24 12,54 +0,97% 2,86% 99.317
14/01/2011 12,24 12,42 12,18 12,42 +1,97% 1,96% 95.217
13/01/2011 12,18 12,30 12,12 12,18 +0,50% 1,48% 107.217
12/01/2011 12,36 12,36 12,12 12,12 -0,49% 1,94% 107.850
11/01/2011 12,24 12,42 12,06 12,18 +0,50% 2,94% 142.650
10/01/2011 12,36 12,42 12,12 12,12 -1,94% 2,43% 142.033
07/01/2011 12,72 12,72 12,30 12,36 -2,37% 3,30% 133.617
06/01/2011 12,90 12,90 12,54 12,66 -0,94% 2,79% 92.767
05/01/2011 12,84 12,84 12,48 12,78 +0,00% 2,80% 76.467
04/01/2011 12,96 13,02 12,60 12,78 -1,39% 3,24% 64.517
03/01/2011 12,66 12,96 12,48 12,96 +3,35% 3,79% 65.200
31/12/2010 12,60 12,72 12,42 12,54 +0,00% 2,38% 82.017
30/12/2010 12,60 12,66 12,42 12,54 +0,48% 1,90% 107.150
29/12/2010 12,90 12,96 12,48 12,48 -2,80% 3,72% 171.833
28/12/2010 12,54 12,96 12,54 12,84 +1,90% 3,35% 175.700
27/12/2010 12,30 12,84 12,24 12,60 +2,44% 4,88% 98.100